CD8A and neoplasm: They constructed an immune scoring system based on the density of interstitial CD8+ TILs, interstitial Foxp3+ TILs, tumor area Foxp3+ TILs, and tumor area PD-1+ TILs, which showed correlations with patient LRFS and OS.